Scientist II, Biomarker Sciences/Translation Sciences

Job description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

As a Scientist II, Biomarker Sciences/Translational Sciences, you will be a key member of the Translational Research team, applying computational approaches to derive biological and translational insights from complex preclinical and clinical datasets. You will:

•
Translational Science: Apply computational approaches to uncover biomarkers, mechanisms of drug response and resistance, pharmacodynamic effects, and therapeutic strategies across translational studies.

•
Omics & Integrated Biology: Analyze and integrate bulk and single-cell sequencing, spatial transcriptomics, and other molecular data with biomarker, pathology, and efficacy/response outcomes to generate actionable biological hypotheses.

•
Scalable Analytics: Develop reproducible analytical workflows and partner on AI-enabled solutions that accelerate exploratory data analysis, visualization, and biological interpretation.

•
Cross-functional Collaboration: Partner across Translational Research, Translational Medicine, Discovery, Bioinformatics, and Information Sciences to address key scientific questions across the portfolio.

•
Analyze and integrate multimodal molecular and phenotypic datasets from translational studies to identify biomarkers, pharmacodynamic effects, mechanisms of response and resistance, and combination hypotheses.

•
Perform cross-study analyses to identify reproducible biological signals and translate computational findings into testable mechanistic and translational hypotheses.

•
Partner with experimental scientists on study design and testing of computationally derived biological hypotheses.

•
Partner with Biomarker Assays teams to translate insights into actionable biomarker analytes.

•
Partner with data science and technology teams to translate scientific needs into scalable analytical and visualization solutions.

•
Evaluate and apply emerging AI/ML approaches to accelerate analysis, data integration, and biological insight generation.

•
Clearly communicate complex analyses and biological conclusions to multidisciplinary project teams and scientific leadership.

Required Skills, Experience and Education:

•
PhD in Cancer Biology, Molecular Oncology, Molecular Medicine, Human Genetics, or a related translational biomedical discipline, with 3+ years of relevant postdoctoral and/or industry experience.

•
Substantial hands-on experience analyzing and biologically interpreting complex omics datasets, including bulk and single-cell sequencing, spatial transcriptomics, and integrated molecular, phenotypic, and clinical/translational data.

•
Strong background in oncology, cancer genomics, and translational biology, with demonstrated ability to independently frame biological questions and translate computational findings into testable hypotheses and drug-development insights.

•
Demonstrated experience and proficiency in applying and evaluating machine learning and emerging AI-enabled approaches to biological data analysis.

•
Proficiency in R and/or Python for the analysis and interpretation of biological data, with a strong commitment to reproducible and rigorous analytical practices.

•
Strong foundation in statistical analysis and experimental design for high-dimensional biological and biomarker data.

•
Strong collaboration and scientific communication skills, with the ability to communicate actionable conclusions to multidisciplinary audiences.

Preferred Skills:

•
Background in oncology drug discovery or development within a biotechnology or pharmaceutical environment.

•
Experience analyzing and interpreting longitudinal baseline, on-treatment, and resistance/progression datasets.

•
Ability to integrate sequencing data with proteomics, pathology, ctDNA, pharmacology, and/or clinical outcomes.

•
Familiarity with cloud-based analytical environments such as Databricks and collaboration on interactive analytical and visualization tools.

•
Knowledge of RAS/MAPK biology and RAS-driven cancers.

#LI-SB1 #LI-Hybrid
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job p

Prepare for the interview

Nothing collected for this employer yet. The Blind 75 is what technical screens draw from; practise it here, with a coach, in Java or Python.

More at Revolution Medicines

• Executive Director, US Portfolio Analytics · Redwood City, California, United States
• Senior Research Associate, DMPK · Redwood City, California, United States
• Senior Administrative Assistant II, Commercialization · Redwood City, California, United States
• Director, Drug Product · Redwood City, California, United States
• Contract Administrator III · Redwood City, California, United States
• Senior Product Manager Oncology, France · Paris, France
• Associate Director, Payroll, Europe · Basel, Switzerland
• Principal Product Manager, Chemistry · Redwood City, California, United States